Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow.
D000818:Animals; D001479:Basal Ganglia; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D006885:Hydroxybutyrates / Q000494:pharmacology*; D008012:Lidocaine / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009411:Nerve Endings; D009431:Neural Conduction; D009638:Norepinephrine / Q000378:metabolism*; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D012965:Sodium Chloride / Q000494:pharmacology; D013378:Substantia Nigra; D013779:Tetrodotoxin / Q000494:pharmacology; D013788:Thalamus
D006885:Hydroxybutyrates; D008781:Methyltyrosines; D013779:Tetrodotoxin; D012965:Sodium Chloride; D011189:Potassium Chloride; D008012:Lidocaine; D004298:Dopamine; D009638:Norepinephrine